Twenty-five years of progress: The view from NIMH and NINDS

Neuron

Volumn 80, Issue 3, 2013, Pages 561-567

  Insel, Thomas R ^a   Landis, Story C ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA INTERFERON; COPOLYMER; FINGOLIMOD; KETAMINE; NEUROLEPTIC AGENT; RAPAMYCIN; TISSUE PLASMINOGEN ACTIVATOR; TRIPTAN DERIVATIVE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEPTH STIMULATION; BRAIN DISEASE; BRAIN FUNCTION; CEREBROVASCULAR ACCIDENT; CYTOLOGY; DEPRESSION; DRUG EFFICACY; DYSTONIA; EPIGENETICS; EPILEPSY; ESSENTIAL TREMOR; FRAGILE X SYNDROME; GENE CONTROL; GENE MUTATION; HUMAN; MEDICAL CARE; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; MIGRAINE; MULTIPLE SCLEROSIS; NATIONAL HEALTH ORGANIZATION; NEURAL STEM CELL; NEUROANATOMY; NEUROBIOLOGY; NEUROSCIENCE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBLICATION; PUBLISHING; REVIEW; TRANSLATIONAL RESEARCH;

ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; UNITED STATES;

EID: 84887006264     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.09.041     Document Type: Review

References (51)

1. Ahrens M.B., Orger M.B., Robson D.N., Li J.M., Keller P.J. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat. Methods 2013, 10:413-420.
2. Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y., et al. De novo mutations in epileptic encephalopathies. Nature 2013, 501:217-221. Epi4K Consortium, Epilepsy Phenome/Genome ProjectEpilepsy Phenome/Genome Project.
3. Bargmann C.I., Marder E. From the connectome to brain function. Nat. Methods 2013, 10:483-490.
4. Batista P.J., Chang H.Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013, 152:1298-1307.
5. Bermel R.A., You X., Foulds P., Hyde R., Simon J.H., Fisher E., Rudick R.A. Predictors of long-term outcome in multiple sclerosis patients treated with interferon β. Ann. Neurol. 2013, 73:95-103.
6. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
7. Bertram L., Tanzi R.E. The genetic epidemiology of neurodegenerative disease. J.Clin. Invest. 2005, 115:1449-1457.
8. Bloom D.E., Cafiero E.T., Jané-Llopis E., Abrahams-Gessel S., Bloom L.R., Fathima S., Feigl A.B., Gaziano T., Mowafi M., Pandya A., et al. The Global Economic Burden of Non-communicable Diseases 2011, World Economic Forum, Geneva.
9. Web-based injury statistics query and reporting system (WISQARS™) 2013, CDC, Centers for Disease Control and Prevention.
10. Chadwick E.K., Blana D., Simeral J.D., Lambrecht J., Kim S.P., Cornwell A.S., Taylor D.M., Hochberg L.R., Donoghue J.P., Kirsch R.F. Continuous neuronal ensemble control of simulated arm reaching by a human with tetraplegia. J.Neural Eng. 2011, 8:034003.
11. Chung K., Wallace J., Kim S.Y., Kalyanasundaram S., Andalman A.S., Davidson T.J., Mirzabekov J.J., Zalocusky K.A., Mattis J., Denisin A.K., et al. Structural and molecular interrogation of intact biological systems. Nature 2013, 497:332-337.
12. Colantuoni C., Lipska B.K., Ye T., Hyde T.M., Tao R., Leek J.T., Colantuoni E.A., Elkahloun A.G., Herman M.M., Weinberger D.R., Kleinman J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011, 478:519-523.
13. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013, 11:126.
14. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 2007, 64:20-24.
15. Demirtas-Tatlidede A., Vahabzadeh-Hagh A.M., Pascual-Leone A. Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?. Neuropharmacology 2013, 64:566-578.
16. Denny C.A., Burghardt N.S., Schachter D.M., Hen R., Drew M.R. 4- to 6-week-old adult-born hippocampal neurons influence novelty-evoked exploration and contextual fear conditioning. Hippocampus 2012, 22:1188-1201.
17. Druss B.G., Walker E.R. Mental disorders and medical comorbidity. The Synthesis Project Research Synthesis Report 2011, 1-26.
18. Dyson F. Imagined worlds 1997, Harvard University Press, Cambridge, MA.
19. Gaj T., Gersbach C.A., Barbas C.F. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013, 31:397-405.
20. Hall Z., Hudspeth A.J., Kandel E., Reichardt L. A new era for neurons. Neuron 1988, 1. 1-1.
21. Hawrylycz M.J., Lein E.S., Guillozet-Bongaarts A.L., Shen E.H., Ng L., Miller J.A., van de Lagemaat L.N., Smith K.A., Ebbert A., Riley Z.L., et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012, 489:391-399.
22. Holtzheimer P.E., Kelley M.E., Gross R.E., Filkowski M.M., Garlow S.J., Barrocas A., Wint D., Craighead M.C., Kozarsky J., Chismar R., et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch. Gen. Psychiatry 2012, 69:150-158.
23. Hurd M.D., Martorell P., Langa K.M. Monetary costs of dementia in the United States. N.Engl. J. Med. 2013, 369:489-490.
24. Hyman S.E. Revolution stalled. Sci. Transl. Med. 2012, 4:155cm111.
25. Insel T.R. From animal models to model animals. Biol. Psychiatry 2007, 62:1337-1339.
26. Insel T.R. Faulty circuits. Sci. Am. 2010, 302:44-51.
27. Insel T.R., Quirion R. Psychiatry as a clinical neuroscience discipline. J.Am. Med. Assoc. 2005, 294:2221-2224.
28. Konermann S., Brigham M.D., Trevino A.E., Hsu P.D., Heidenreich M., Cong L., Platt R.J., Scott D.A., Church G.M., Zhang F. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013, 500:472-476.
29. Krey J.F., Paşca S.P., Shcheglovitov A., Yazawa M., Schwemberger R., Rasmusson R., Dolmetsch R.E. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 2013, 16:201-209.
30. Krueger D.A., Wilfong A.A., Holland-Bouley K., Anderson A.E., Agricola K., Tudor C., Mays M., Lopez C.M., Kim M.O., Franz D.N. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann. Neurol. 2013, Published online June 24, 2013.
31. Linden D.E., Habes I., Johnston S.J., Linden S., Tatineni R., Subramanian L., Sorger B., Healy D., Goebel R. Real-time self-regulation of emotion networks in patients with depression. PLoS ONE 2012, 7:e38115.
32. Lipton R.B. Headache in 2010: progress in headache mechanisms and management. Nat Rev Neurol 2011, 7:67-68.
33. Lister R., Mukamel E.A., Nery J.R., Urich M., Puddifoot C.A., Johnson N.D., Lucero J., Huang Y., Dwork A.J., Schultz M.D., et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905.
34. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global Burden of Disease and Risk Factors 2006, The World Bank and Oxford University Press, New York, NY.
35. Martinowich K., Jimenez D.V., Zarate C.A., Manji H.K. Rapid antidepressant effects: moving right along. Mol. Psychiatry 2013, 18:856-863.
36. Michalon A., Sidorov M., Ballard T.M., Ozmen L., Spooren W., Wettstein J.G., Jaeschke G., Bear M.F., Lindemann L. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012, 74:49-56.
37. Miocinovic S., Somayajula S., Chitnis S., Vitek J.L. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol 2013, 70:163-171.
38. Nawaratne V., Leach K., Suratman N., Loiacono R.E., Felder C.C., Armbruster B.N., Roth B.L., Sexton P.M., Christopoulos A. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug). Mol. Pharmacol. 2008, 74:1119-1131.
39. Neligan A., Bell G.S., Johnson A.L., Goodridge D.M., Shorvon S.D., Sander J.W. The long-term risk of premature mortality in people with epilepsy. Brain 2011, 134:388-395.
40. Sahay A., Wilson D.A., Hen R. Pattern separation: a common function for new neurons in hippocampus and olfactory bulb. Neuron 2011, 70:582-588.
41. Smart O., Maus D., Marsh E., Dlugos D., Litt B., Meador K. Mapping and mining interictal pathological gamma (30-100Hz) oscillations with clinical intracranial EEG in patients with epilepsy. Expert Syst. Appl. 2012, 39:7355-7370.
42. Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379. Cross-Disorder Group of the Psychiatric Genomics Consortium.
43. Stacey W.C., Litt B. Technology insight: neuroengineering and epilepsy-designing devices for seizure control. Nat. Clin. Pract. Neurol. 2008, 4:190-201.
44. Stankiewicz J.M., Kolb H., Karni A., Weiner H.L. Role of immunosuppressive therapy for the treatment of multiple sclerosis. Neurotherapeutics 2013, 10:77-88.
45. Toledo J.B., Xie S.X., Trojanowski J.Q., Shaw L.M. Longitudinal change in CSF Tau and Aβ biomarkers for up to 48months in ADNI. Acta Neuropathol. 2013, Published online June 29, 2013. 10.1007/s00401-013-1151-4.
46. Tye K.M., Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat. Rev. Neurosci. 2012, 13:251-266.
47. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, Published online August 29, 2013. 10.1016/S0140-6736(13)61611-6.
48. Wadman M. The NIH faces up to hard times. Nature 2012, Published online September 26, 2012. 10.1038/nature.2012.11458.
49. Wichterle H., Gifford D., Mazzoni E. Neuroscience. Mapping neuronal diversity one cell at a time. Science 2013, 341:726-727.
50. Yates L.A., Norbury C.J., Gilbert R.J. The long and short of microRNA. Cell 2013, 153:516-519.
51. Zhu Z.R., Huangfu D.W. Human pluripotent stem cells: an emerging model in developmental biology. Development 2013, 140:705-717.